New Hybrid Technology for Faster Stroke Diagnosis
Researchers in Europe will develop a new hybrid device that combines different imaging technologies and will help stroke patients in particular to receive quicker diagnosis and treatment. The project "Predictive Prevention and Personalised Interventional Stroke Therapy - P3 Stroke" is being undertaken by University of Erlangen-Nuremberg (FAU), in collaboration with Siemens Healthcare GmbH, Universitätsklinikum Erlangen and other European partners.
See Also: 4D Imaging Software Predicts Stroke Risk
"With the P3 Stroke project we want to improve the diagnosis and interventional treatment of strokes on a fundamental level by combining the use of magnetic resonance imaging and angiography," explains Dr. Heinrich Kolem, CEO of Advanced Therapies at Siemens Healthineers.
This innovative approach will be used for diagnosis and immediate treatment, reducing the time needed for patient transfers and saving valuable time when treating stroke patients. Conducting separate examinations using different devices takes time, particularly due to the need to transfer patients between locations. An average of two million neurons are destroyed every minute, thus every minute counts during efforts to prevent major damage after a stroke.
"The pioneering system enables an exact picture of the development of the condition to be obtained without delay, allowing for effective treatment," says Prof. Dr. Arnd Dörfler, head of the Department of Neuroradiology at Universitätsklinikum Erlangen, and a leader of the research team. The clinical evaluation of the new methods will be led by the Department of Neuroradiology at Universitätsklinikum Erlangen in close collaboration with the Department of Neurology.
Meanwhile, the Pattern Recognition Lab at FAU is responsible for developing the software. "We have been conducting research in various areas of medical imaging for many years and can therefore contribute a considerable amount of expertise," according to Prof. Dr. Andreas Maier, head of the lab and co-leader of the research team.
The new technology is expected to benefit not just stroke patients but other patient groups as well. As Professor Dörfler points out: "The system will also have applications in minimally invasive treatment for other neuro- and cardiovascular disorders and in oncology."
The P3 Stroke project is being funded by the European Institute of Innovation and Technology for Health (EIT Health), a publicly financed initiative that aims to ensure sustainable development of innovative healthcare solutions.
Source: University of Erlangen-Nuremberg
Image Credit: Colourbox.de
Published on : Mon, 19 Dec 2016
Print as PDF
The SonoSite EDGE II is a high-resolution, all-digital, 9.0-pound (4.1 kg) ultrasound system with a 12.1in. LED full-bleed glass display. The Edge II boosts improvements in cardiac and abdominal image quality through DirectClear Technology and a new wide-angle...
The SonoSite SII features a new touchscreen user interface with a clinician-driven menu logic that adaptively adjusts to your imaging needs – “what you need, is what you see”. An embedded dual transducer connector allows you to quickly switch between...
We recognize that the best chance any patient has at getting better is a clinician at their bedside with all the right answers and the confidence to act. SonoSite education and training is the industry standard – no other point-of-care ultrasound manufacturer...